US2021017239A1PendingUtilityA1

Proteins with diagnostic and therapeutic uses

Assignee: UNIV COURT UNIV OF EDINBURGHPriority: Oct 14, 2013Filed: Aug 17, 2020Published: Jan 21, 2021
Est. expiryOct 14, 2033(~7.2 yrs left)· nominal 20-yr term from priority
A61P 7/00A61P 13/12A61K 38/00C07K 14/472A61L 27/54G01N 2333/3156C07K 14/3156A61P 25/28A61P 27/02A61P 17/00A61L 27/34A61K 38/164A61K 9/48G01N 2333/4716A61L 31/10A61L 31/16A61P 13/02A61L 29/085A61L 29/16
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A recombinant protein for use in the treatment of one or more medical complications associated with aberrant complement regulatory activity in a subject, the recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH.

Claims

exact text as granted — not AI-modified
1 . A recombinant protein for use in the treatment of one or more medical complications associated with aberrant complement regulatory activity in a subject, the recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH. 
     
     
         2 . The recombinant protein of  claim 1 , wherein the protein is capable of binding to wild type CFH to form a complex with a K D  of 1×10 −10  M or lower. 
     
     
         3 . The recombinant protein of  claim 1 , wherein the protein is derived from a bacterial virulence factor. 
     
     
         4 . The recombinant protein of  claim 2 , wherein the protein is derived from a bacterial virulence factor. 
     
     
         5 . The recombinant protein of  claim 1 , wherein the protein is derived from a pneumococcal surface protein. 
     
     
         6 . The recombinant protein of  claim 5 , wherein the protein is derived from pneumococcal surface protein C (PspC) from  Streptococcus pneumoniae.    
     
     
         7 . The recombinant protein of  claim 5 , wherein the protein is derived from PspC of strain D39 (NCTC no 7466) of  S. pneumoniae  or PspC of strain TIGR4 (NCTC no 7465) of  S. pneumoniae.    
     
     
         8 . The recombinant protein of  claim 5 , wherein the protein comprises a fragment of PspC, or a variant thereof, which is from 70 to 150 amino acids in length. 
     
     
         9 . The recombinant protein of  claim 2 , wherein the protein is derived from a pneumococcal surface protein. 
     
     
         10 . The recombinant protein of  claim 9 , wherein the protein is derived from pneumococcal surface protein C (PspC) from  Streptococcus pneumoniae.    
     
     
         11 . The recombinant protein of  claim 9 , wherein the protein is derived from PspC of strain D39 (NCTC no 7466) of  S. pneumoniae  or PspC of strain TIGR4 (NCTC no 7465) of  S. pneumoniae.    
     
     
         12 . The recombinant protein of  claim 9 , wherein the protein comprises a fragment of PspC, or a variant thereof, which is from 70 to 150 amino acids in length. 
     
     
         13 . The recombinant protein of  claim 1 , wherein the protein comprises the sequence: 
       
         
           
                 
               
                   (SEQ ID NO 1) 
                 
                   ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK 
                 
                     
                 
                   HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE 
                 
                     
                 
                   KFKKDTLKPGEK, 
                 
             
                
                
                
                
                
                
               
            
           
         
         or a functional variant or fragment thereof; or 
         KQVVDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or 
         ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof. 
       
     
     
         14 . The recombinant protein of  claim 2 , wherein the protein comprises the sequence: 
       
         
           
                 
               
                   (SEQ ID NO 1) 
                 
                   ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK 
                 
                     
                 
                   HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE 
                 
                     
                 
                   KFKKDTLKPGEK, 
                 
             
                
                
                
                
                
                
               
            
           
         
         or a functional variant or fragment thereof; or 
         KQWDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or 
         ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof. 
       
     
     
         15 . The recombinant protein of  claim 5 , wherein the protein comprises the sequence: 
       
         
           
                 
               
                   (SEQ ID NO 1) 
                 
                   ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK 
                 
                     
                 
                   HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE 
                 
                     
                 
                   KFKKDTLKPGEK, 
                 
             
                
                
                
                
                
                
               
            
           
         
         or a functional variant or fragment thereof; or KQVVDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or 
         ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof. 
       
     
     
         16 . The recombinant protein of  claim 6 , wherein the protein comprises at least amino acids 68-136 of PspC, or a functional variant thereof. 
     
     
         17 . The recombinant protein of  claim 1 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH. 
     
     
         18 . The recombinant protein of  claim 5 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH. 
     
     
         19 . The recombinant protein of  claim 9 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH.

Join the waitlist — get patent alerts

Track US2021017239A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.